Jivaro — Clinical Trials Search Guide: How to Find Studies and Read Results Fields

Quick answer: what is a clinical trials search workflow?

A clinical trials search workflow is a repeatable way to look up studies without turning a registry listing into a medical conclusion. Instead of typing one disease name into ClinicalTrials.gov and clicking the first result, you define your question, search by condition and intervention, filter the results, read the record, check endpoints and results fields, then bring better questions to a qualified clinician.

This guide is for health-curious readers, patients, caregivers, students, researchers, science writers, and anyone who wants a calmer way to search clinical trials before a clinical conversation. It is a health-literacy workflow, not medical advice, trial enrollment advice, diagnosis, treatment guidance, or a substitute for a clinician.

Important safety note: Do not join, avoid, start, stop, or change any treatment because of a trial listing. Eligibility, risks, informed consent, costs, insurance, travel, study visits, placebo or control arms, and your current care plan should be discussed with the study team and your own clinician.

Use the downloadable worksheet

The ClinicalTrials.gov Finder Workflow worksheet is designed to help you log the same fields every time: condition, intervention, NCT ID, recruitment status, phase, age range, sex eligibility, country or location, sponsor, study type, enrollment, outcomes, dates, results availability, publications, exclusions, and clinician questions.

Find the worksheet in Jivaro Research Preview the worksheet fields

Why ClinicalTrials.gov is useful—and what it cannot tell you

ClinicalTrials.gov is an online database of clinical research studies and information about their results. NIH describes it as a searchable registry and results database for federally and privately supported trials conducted in the United States and around the world. It can show a study’s purpose, who may participate, locations, and contact information, but NIH also emphasizes that the information should be used with advice from health care professionals.

What it can help you find

Studies related to a condition, symptom, intervention, device, behavior, diagnostic test, or prevention strategy.
Recruitment status, such as recruiting, not yet recruiting, active but not recruiting, completed, terminated, or withdrawn.
Study phase when applicable, especially for drug and biologic trials.
Age range, sex eligibility, location, sponsor, study type, enrollment, eligibility criteria, outcomes, and key dates.
Whether results are posted and whether publications or references are linked.

What it cannot decide for you

Whether a treatment works for you personally.
Whether a recruiting study is safe, effective, practical, affordable, or appropriate for your care plan.
Whether you are truly eligible; eligibility is determined by the study team using detailed criteria.
Whether published results, registry results, and your clinician’s judgment point in the same direction.
Whether a study listing has been evaluated or endorsed by the U.S. Federal Government; NIH cautions that a listing does not mean that.

The ClinicalTrials.gov Finder Workflow

Use this eight-step workflow when you want a structured clinical trials search by condition, intervention, phase, location, status, or results availability. The goal is not to produce a yes/no decision. The goal is to leave with a clean shortlist, a record of what you checked, and better questions.

Define the question. Write down the condition, intervention, population, and goal. For example: “Adults with IBS; peppermint oil, probiotics, or diet intervention; symptom improvement; studies with posted results.”
Search ClinicalTrials.gov using condition and intervention terms. Start broad, then add terms. Use both plain-language and clinical-language words when relevant.
Filter by status, phase, age, location, sponsor, and results availability. Narrow slowly. Too many filters too early can hide useful records.
Open promising records and capture the basics. Log the NCT ID, title, status, phase, sponsor, locations, enrollment, and eligibility criteria.
Read primary and secondary outcome measures before reading conclusions. The outcome fields tell you what the study is actually trying to measure.
Check whether results are posted and publications are linked. A completed trial does not automatically mean results are posted or published.
Note limitations. Watch for missing results, incomplete enrollment, narrow eligibility, short follow-up, sponsor context, and outcomes that do not match your real question.
Turn the search into clinician questions. Bring one to three relevant NCT IDs, the outcome measures, and your questions to your clinician or the study contact.

Clinical trial finder worksheet with organized fields for condition, intervention, status, phase, location, outcomes, results, publications, and clinician questions. — Worksheet illustration: keep search terms, filters, endpoints, and clinician questions in one place.

Clinical Trial Search Fields

The worksheet works because it makes you slow down. Instead of saving a trial title and forgetting why it looked relevant, log each field in the same order. This is especially useful when comparing studies with different phases, locations, endpoints, or results status.

Field	What it means	Why it matters	What to watch out for	Worksheet note
Condition	The disease, symptom, diagnosis, or health state being studied.	It anchors the search and prevents irrelevant intervention-only results.	Broad terms may mix different diagnoses, stages, severities, or subtypes.	Record the exact term used plus synonyms you tried.
Intervention/treatment	The drug, device, procedure, diet, supplement, behavior, diagnostic, or care strategy being studied.	It helps you separate studies about the same condition but different approaches.	Brand names, generic names, drug classes, and related interventions may return different records.	Log generic names, brand names, class terms, and spelling variants.
Recruitment status	Whether the study is recruiting, not yet recruiting, active but not recruiting, completed, terminated, withdrawn, or another status.	It shows where the study appears to be in its recruitment timeline.	Recruiting does not mean the intervention works; completed does not mean results are posted.	Write the status and the date you checked it.
Phase	The development stage for many interventional drug or biologic trials.	It helps you understand whether the study is early safety-focused, later efficacy-focused, post-marketing, or not phase-classified.	Do not treat a higher phase as proof of benefit or a lower phase as irrelevant.	Record the phase exactly, including “Not Applicable” when shown.
Age	The minimum and maximum ages eligible for the study.	Age criteria can immediately rule a study in or out for discussion.	Some studies use narrow age bands or pediatric/adult/older-adult criteria.	Log the age range and whether it matches the person’s situation.
Sex eligibility	Whether the study includes female, male, or all participants as defined by the record.	Eligibility can affect relevance, safety screening, and applicability.	Sex eligibility may interact with pregnancy, contraception, hormone therapy, or disease-specific criteria.	Record the field and any related eligibility notes.
Country/location	Where the study sites are listed.	Travel, follow-up visits, language, site access, and timing can determine practicality.	Location listings may change, and some sites may not be actively enrolling even when a study is recruiting.	Log countries, nearby sites, and contact details if relevant.
Sponsor/collaborator	The organization responsible for the study and any listed collaborators.	Sponsor context helps you understand whether a study is industry, academic, government, nonprofit, or collaborative.	Sponsor type does not automatically prove quality or bias; it is context to discuss.	Record sponsor, collaborator, and any funding context you want to ask about.
Study type	Whether the record is interventional, observational, expanded access, or another listed type.	It changes how you interpret the record. Observational studies do not assign participants to an intervention the same way trials do.	Do not read observational findings like randomized trial evidence.	Log study type and design details such as randomization or masking when shown.
Enrollment	The number of participants planned, estimated, or actually enrolled, depending on the record.	Enrollment affects how much weight you should place on a record and whether the study appears feasible.	Small or incomplete enrollment can limit interpretation; estimated enrollment may change.	Write the number and whether it appears estimated or actual.
Primary outcome	The main measure the study is designed to evaluate.	It tells you what the study is really built around.	The primary outcome may not be the outcome you personally care about most.	Copy the outcome title, measure, and time frame.
Secondary outcomes	Additional measures beyond the primary outcome.	They can show safety, symptoms, quality of life, biomarkers, durability, or other supporting questions.	Secondary outcomes are easy to overinterpret, especially if many are listed.	Capture the most relevant secondary outcomes and time frames.
Start/completion dates	Study start, primary completion, and study completion timing.	Dates help you understand whether results might reasonably be available and whether a study is recent or older.	Primary completion and final study completion are not the same thing.	Log start date, primary completion date, study completion date, and whether dates are estimated or actual.
Results posted	Whether summary results are available in the ClinicalTrials.gov record.	Posted results can show participant flow, baseline characteristics, outcome measures, and adverse events fields.	Results fields are not the same as medical advice or a full peer-reviewed interpretation.	Mark yes/no, date checked, and which results sections you reviewed.
Publications/references	Linked papers, citations, or references associated with the study record.	Publications may provide fuller methods, analysis, limitations, and context.	Not every record has linked publications, and not every publication answers every registry question.	Paste publication links and note whether you read the abstract or full paper.
NCT ID	The ClinicalTrials.gov identifier for the study record.	It is the cleanest way to find, save, compare, and discuss a specific record.	Do not rely on title alone; similar titles can be confusing.	Copy the NCT ID exactly and use it in clinician or study-team questions.

How to read a study record without overinterpreting it

The ClinicalTrials.gov guide to reading a study record is worth opening before you compare studies. A record is not a headline. It is a structured summary with study status, design, eligibility, locations, contacts, outcomes, dates, and sometimes results.

Read in this order

NCT ID and brief title: Confirm you are looking at the exact record you intended to open.
Status and dates: Check whether the record is recruiting, active, completed, or otherwise labeled, and note the last update context.
Study type and phase: Decide whether it is interventional or observational, and whether phase is relevant.
Eligibility criteria: Read inclusion and exclusion criteria before assuming the study applies to you.
Arms, interventions, and controls: Look for placebo, standard-care, comparator, or no-intervention groups.
Primary outcome: Read the main endpoint and time frame before reading summaries or interpretations.
Secondary outcomes and safety fields: Look for symptom, quality-of-life, biomarker, adverse-event, or follow-up measures.
Results and publications: Check whether registry results are posted and whether papers are linked.

Plain-English rule: A study record can tell you what the researchers planned, measured, and reported. It cannot tell you what you should do medically without clinical context.

How to read clinical trial results fields

When results are posted, move slowly. The ClinicalTrials.gov results data element definitions explain structured results fields, while the protocol data element definitions explain many registration fields. For a reader, the main job is to understand what is being measured before reacting to whether something sounds positive.

Four places to slow down

Participant flow: Did people start, complete, drop out, or move through groups as expected?
Baseline characteristics: Who was actually included, and does that population resemble the question you care about?
Outcome measures: Did the results report the same primary and secondary outcomes listed in the study plan?
Adverse events: What safety events were reported, and how were they distributed across groups?

Posted results are useful, but they are not the whole interpretation. Look for linked publications, methods details, statistical analysis, limitations, missing data, and clinical relevance. If you do not understand an endpoint, copy it into your worksheet and ask your clinician what it means in real-world care.

Three neutral clinical trial search workflow cards for GLP-1 metabolic outcomes, IBS symptom outcomes, and aging or frailty studies. — Example-search illustration: three search paths that show logic and fields, not treatment conclusions.

Three example workflows

These examples show search logic only. They do not claim that any specific trial is recruiting, available, safe, effective, or appropriate. Trial records and statuses change, so verify any record directly on ClinicalTrials.gov before discussing it.

1. GLP-1 and metabolic outcomes

Search logic: Start with condition terms such as obesity, overweight, type 2 diabetes, metabolic dysfunction, cardiovascular risk, kidney disease, or liver-related metabolic outcomes. Then add intervention terms such as semaglutide, tirzepatide, GLP-1 receptor agonist, dual agonist, incretin, or a specific generic name.

Filters to try: Recruiting status, completed studies, Phase 2/3/4, adult age range, country or site, results posted, and sponsor type.

Fields to log: NCT ID, phase, enrollment, dose or intervention name, comparator, primary outcome, follow-up length, adverse-event fields, and whether publications are linked.

Clinician questions: “Does this endpoint match my goal?” “How does the study population compare with my health history?” “Could this affect current medications or monitoring?”

2. IBS, gut-brain, and symptom outcomes

Search logic: Try condition terms such as irritable bowel syndrome, IBS, functional bowel disorder, abdominal pain, bloating, diarrhea, constipation, or disorders of gut-brain interaction. Add intervention terms such as peppermint oil, probiotics, diet, low-FODMAP, behavioral therapy, gut-brain, or symptom scale.

Filters to try: Adult or pediatric age, study type, recruiting or completed status, results posted, country, and whether the intervention is dietary, behavioral, microbiome-related, or drug-related.

Fields to log: IBS subtype, eligibility criteria, symptom-score endpoint, stool-pattern endpoint, quality-of-life measure, duration, control arm, and adverse events.

Clinician questions: “Does this trial match my IBS subtype?” “What standard-care options should I understand first?” “What outcome scale is being used, and is it meaningful for my symptoms?”

3. Aging, frailty, and healthy-aging outcomes

Search logic: Start with aging, frailty, sarcopenia, physical function, exercise, healthy aging, cognitive aging, or mobility. Then add intervention terms such as exercise, resistance training, metformin, rapamycin, senolytics, NAD-related terms, nutrition, or multimodal lifestyle intervention.

Filters to try: Older adult age ranges, interventional versus observational studies, recruiting or completed status, results posted, country, phase when applicable, and sponsor type.

Fields to log: Primary outcome, functional measure, biomarker measure, follow-up duration, inclusion/exclusion criteria, enrollment, comparator, adverse-event reporting, and publications.

Clinician questions: “Is this measuring lifespan, healthspan, function, a biomarker, or disease risk?” “Are the risks reasonable for my age and medical history?” “Is this intervention already used for another condition?”

Common mistakes when reading ClinicalTrials.gov

Most mistakes come from treating a registry record like a recommendation. Use the record as a structured starting point instead.

Recruiting ≠ proven

A recruiting trial is looking for participants. It is not proof that the intervention works.

Eligibility is not optional

Inclusion and exclusion criteria may rule out people who otherwise seem like a match.

Endpoints matter

Do not focus only on the intervention. Read what the trial is actually measuring.

Phase can be misunderstood

A Phase 1 safety study should not be read like a proven-efficacy study.

Completed ≠ results posted

A completed study may not have posted results or linked publications.

Results fields ≠ medical advice

Registry results need clinical context, methods review, and careful interpretation.

Control arms matter

Check whether participants may receive placebo, standard care, or another comparator.

Safety fields matter

Do not skip adverse-event fields, discontinuations, or burdens of participation.

Clinicians belong in the loop

Bring NCT IDs and questions to a qualified clinician before making care decisions.

Printed clinical trial record and clinician-question worksheet with notes about eligibility, risks, control arms, travel, insurance, and follow-up care. — Clinician-question illustration: turn registry findings into specific, safer questions for a qualified professional.

Questions to ask your clinician or the study team

The best output of a clinical trials search is not a decision. It is a better conversation. Bring a short list of NCT IDs, the primary outcomes, eligibility notes, and these questions.

Does this trial match my diagnosis and medical history?
What standard-care options should I understand first?
What are the main risks and burdens of participation?
Could I receive placebo or standard care instead of the intervention?
What outcomes is the trial actually measuring?
Are the results posted, published, or still pending?
Would joining affect my current medications, procedures, insurance, travel, or follow-up care?
Who do I contact if I am interested, and what should I ask the study team?

Turn the search into a safer conversation

Use the worksheet to capture one to three relevant records, then discuss them with a qualified clinician. The goal is to understand fit, risk, burden, standard-care alternatives, and what the trial is truly measuring.

Visit the Jivaro Research hub Read the research-literacy guide

FAQ: clinical trials search basics

Is ClinicalTrials.gov medical advice?

No. It is a study registry and results database. Use it to find and understand records, then discuss the details with a qualified clinician.

Does “recruiting” mean a treatment works?

No. Recruiting means the study is seeking participants. It does not prove safety, effectiveness, approval, or personal fit.

Why read endpoints before conclusions?

Endpoints show what the trial is actually measuring. A study may measure a biomarker, symptom score, safety outcome, or clinical event, and those are not interchangeable.

What does “results posted” mean?

It means summary results fields are available in the record. It does not automatically mean the results are published, definitive, or applicable to your situation.

What is an NCT ID?

It is the ClinicalTrials.gov identifier for a specific study record. Copying it helps you return to the same record and ask precise questions.

What if a trial has no posted results?

Do not assume the outcome. Note the missing result fields, check for linked publications, and ask your clinician or the study contact what is known.

Official resources used in this workflow

These official pages are the best places to confirm definitions, search guidance, and study-record structure before relying on a secondary summary.

Last source review for this draft: June 13, 2026.

Clinical Trials Search Guide: How to Find Studies and Read Results Fields